Donepezil in a Narrow Concentration Range Augments Control and Impaired by Beta-Amyloid Peptide Hippocampal LTP in NMDAR-Independent Manner

[1]  Xiao-Liang Wang,et al.  Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. , 2011, European journal of pharmacology.

[2]  M. Martín-Satué,et al.  Amyloid β peptide oligomers directly activate NMDA receptors. , 2011, Cell calcium.

[3]  V. Skrebitskii,et al.  Donepezil Eliminates Suppressive Effects of β-Amyloid Peptide (1-42) on Long-Term Potentiation in the Hippocampus , 2010, Bulletin of Experimental Biology and Medicine.

[4]  Mu-Ming Poo,et al.  Spike-Timing Dependent Plasticity Beyond Synapse – Pre- and Post-Synaptic Plasticity of Intrinsic Neuronal Excitability , 2010, Front. Syn. Neurosci..

[5]  K. Fukunaga,et al.  Galantamine enhancement of long‐term potentiation is mediated by calcium/calmodulin‐dependent protein kinase II and protein kinase C activation , 2009, Hippocampus.

[6]  C. Masters,et al.  beta-Amyloid as a molecular therapeutic target in Alzheimer's disease. , 2009, Drugs of Today.

[7]  E. Godaux,et al.  Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice , 2009, Neurobiology of Aging.

[8]  R. Anwyl,et al.  Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus , 2009, The European journal of neuroscience.

[9]  A. Akaike,et al.  Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection , 2009, Journal of Molecular Neuroscience.

[10]  Ming Wang,et al.  Modulation of long‐term potentiation by individual subtypes of muscarinic acetylcholine receptor in the rat dentate gyrus , 2008, Hippocampus.

[11]  Justin W. Kenney,et al.  Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine , 2008, Molecular Neurobiology.

[12]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[13]  N. Relkin.  Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer’s disease , 2007, Expert review of neurotherapeutics.

[14]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[15]  V. Skrebitsky,et al.  Donepezil is a strong antagonist of voltage-gated calcium and potassium channels in molluscan neurons. , 2007, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[16]  J. Ieni,et al.  The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor , 2006, British journal of pharmacology.

[17]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[18]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[19]  N. Kato,et al.  Mechanism of impairment of long-term potentiation by amyloid β is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons , 2005, Neuroscience Letters.

[20]  Manuela G. López,et al.  Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.

[21]  S. Moriguchi,et al.  Modulation of N-Methyl-d-aspartate Receptors by Donepezil in Rat Cortical Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.

[22]  Nigel Emptage,et al.  Ca2+ and synaptic plasticity. , 2005, Cell calcium.

[23]  H. Ogura,et al.  Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons , 2005, Brain Research.

[24]  J. Hoh,et al.  Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology* , 2005, Journal of Biological Chemistry.

[25]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.

[26]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[27]  D. Budai,et al.  Enhancement of NMDA responses by &bgr;-amyloid peptides in the hippocampus in vivo , 2004, Neuroreport.

[28]  J. Standridge.  Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. , 2004, Clinical therapeutics.

[29]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[30]  W. Abraham,et al.  NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus , 2003, Brain Research.

[31]  T. Shimahara,et al.  Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus , 2002, Neurobiology of Learning and Memory.

[32]  Y. Kuriya,et al.  Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. , 2000, European journal of pharmacology.

[33]  L. Ye,et al.  Suppressive action produced by β-amyloid peptide fragment 31–35 on long-term potentiation in rat hippocampus is N-methyl-d-aspartate receptor-independent: it's offset by (−)huperzine A , 1999, Neuroscience Letters.

[34]  Koki Kato,et al.  TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons , 1999, Neuroscience Letters.

[35]  G. Collingridge,et al.  Ca2+ and synaptic plasticity. , 1998, Cell calcium.

[36]  R. Mohs,et al.  Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. , 1998, Archives of internal medicine.

[37]  H. Haas,et al.  A simple perfusion system for patch-clamp studies , 1996, Journal of Neuroscience Methods.

[38]  M. Krug,et al.  Fucose and fucosyllactose enhance in-vitro hippocampal long-term potentiation , 1996, Brain Research.

[39]  R. Anwyl,et al.  beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. , 1995, Neuroreport.

[40]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[41]  Christian Rosenmund,et al.  Rundown of N‐methyl‐D‐aspartate channels during whole‐cell recording in rat hippocampal neurons: role of Ca2+ and ATP. , 1993, The Journal of physiology.

[42]  L. Vyklický.  Calcium‐mediated modulation of N‐methyl‐D‐aspartate (NMDA) responses in cultured rat hippocampal neurones. , 1993, The Journal of physiology.

[43]  R. Dingledine,et al.  Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. , 1992, Molecular pharmacology.

[44]  Vladimir S. Vorobjev,et al.  Vibrodissociation of sliced mammalian nervous tissue , 1991, Journal of Neuroscience Methods.

[45]  Rundown of N‐methyl‐ d‐aspartate channels during whole‐cell recording in rat hippocampal neurons: role of Ca2+ and ATP , 2022 .